Drug Intelligence provides syndicated audits to ensure data consistency, timeliness and accuracy while considerably lowering clients’ costs.

Depending on the specific needs of the clients, Drug Intelligence can undertake customized audits based on the following key components:

Drug Intelligence can rapidly and accurately monitor post-launch performance of newly introduced products to get better insights on any course corrections (at a strategic or tactical level) and the evolving competitive dynamics.

Drug Intelligence has a separate division that provides clients specialized services in scientific and clinical support to enhance their marketing and clinical efforts.